Profil
Sheng Cui currently works at NewAmsterdam Pharma Co. NV, as Chief Manufacturing Officer from 2023.
Dr. Cui also formerly worked at Amgen, Inc., as Scientific Director from 2018 to 2019 and Boston Pharmaceuticals, Inc., as Head-Chemistry Manufacturing & Controls from 2020 to 2021.
Dr. Cui received his doctorate degree from Case Western Reserve University and undergraduate degree from Nankai University.
Postes actifs de Sheng Cui
| Sociétés | Poste | Début |
|---|---|---|
| FRAZIER LIFESCIENCES ACQUISITION CORPORATION | Corporate Officer/Principal | 01/04/2021 |
Anciens postes connus de Sheng Cui
| Sociétés | Poste | Fin |
|---|---|---|
Boston Pharmaceuticals, Inc.
Boston Pharmaceuticals, Inc. Miscellaneous Commercial ServicesCommercial Services Operates as a clinical stage biopharmaceutical company that develops therapies for patients | Corporate Officer/Principal | 01/04/2021 |
| AMGEN INC. | Directeur Technique/Scientifique/R&D | 01/03/2019 |
Formation de Sheng Cui
Expériences
Fonctions occupées
Actives
Inactives
Sociétés cotées
Entreprise privées
Relations
Relations au 1er degré
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Entreprise privées | 5 |
|---|---|
Amgen, Inc.
Amgen, Inc. BiotechnologyHealth Technology Discovers, develops, manufactures and delivers human therapeutics | Health Technology |
Case Western Reserve University
Case Western Reserve University Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Nankai University
Nankai University Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Boston Pharmaceuticals, Inc.
Boston Pharmaceuticals, Inc. Miscellaneous Commercial ServicesCommercial Services Operates as a clinical stage biopharmaceutical company that develops therapies for patients | Commercial Services |
NewAmsterdam Pharma Co. NV
NewAmsterdam Pharma Co. NV Pharmaceuticals: MajorHealth Technology Operates as a biopharmaceutical company that researches, develops, manufactures and commercializes transformative therapies for cardio-metabolic diseases | Health Technology |
















